DUBLIN, June 2, 2021 /CNW/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 4,120 individuals on the MiniMed™ 780G system, a ...

Medtronic presents new data on MiniMed™ 780G system on fixed meal dosing and real-world Time in Range across wide variety of users PR Newswire - Fri Jun 23, 2023 ...

As Medtronic advances its SmartGuard™ algorithm towards a fully closed loop system, the company is evaluating the use of its MiniMed 780G system integrated with its proprietary Klue smartwatch ...

DUBLIN and SAN DIEGO, June 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the ...

The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as ...

Medtronic plc ’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as ...

Medtronic's introduction of the MiniMed 780G continuous glucose monitoring system and acquisition of EOFlow Co. Ltd. could inspire growth, but will be subject to fierce competition.

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 ...

Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring.

DUBLIN and SAN DIEGO, June 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on ...